For: | Li H, Wang JS, Mu LJ, Shan KS, Li LP, Zhou YB. Promotion of Sema4D expression by tumor-associated macrophages: Significance in gastric carcinoma. World J Gastroenterol 2018; 24(5): 593-601 [PMID: 29434448 DOI: 10.3748/wjg.v24.i5.593] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v24/i5/593.htm |
Number | Citing Articles |
1 |
Bo Zhang, Tianyu Miao, Xin Shen, Lirong Bao, Cheng Zhang, Caixia Yan, Wei Wei, Jiao Chen, Liying Xiao, Chongkui Sun, Jintao Du, Yan Li. EB virus-induced ATR activation accelerates nasopharyngeal carcinoma growth via M2-type macrophages polarization. Cell Death & Disease 2020; 11(9) doi: 10.1038/s41419-020-02925-9
|
2 |
Yan-Ting Li, Wen-Zhen Yuan, Wei-Lin Jin. Vagus innervation in the gastrointestinal tumor: Current understanding and challenges. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2023; 1878(3): 188884 doi: 10.1016/j.bbcan.2023.188884
|
3 |
Ke Wang, Xin-hui Zhao, Jun Liu, Rui Zhang, Ji-peng Li. Nervous system and gastric cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2020; 1873(1): 188313 doi: 10.1016/j.bbcan.2019.188313
|
4 |
Li Xue, Shulan Shi, Hongtao Lei, Zhen Zhang, Xin Tian, Lijuan Qiu, Jiaolian Tang, Liyue Kui, Weiwei Nan, Xiaoyue Cao, Qiangming Sun, Ming Yu, Hongchao Jiang, Naoshad Muhammad. Soluble Sema4D Level Is Positively Correlated with Sema4D Expression in PBMCs and Peripheral Blast Number in Acute Leukemia. Disease Markers 2022; 2022: 1 doi: 10.1155/2022/1384471
|
5 |
Sichao Chen, Zeming Liu, Man Li, Yihui Huang, Min Wang, Wen Zeng, Wei Wei, Chao Zhang, Yan Gong, Liang Guo. Potential Prognostic Predictors and Molecular Targets for Skin Melanoma Screened by Weighted Gene Co-expression Network Analysis. Current Gene Therapy 2020; 20(1): 5 doi: 10.2174/1566523220666200516170832
|
6 |
Zhenxing Wang, Yan Zhao, Hongyan Xu, Feihai Liang, Qingxu Zou, Chen Wang, Jingyuan Jiang, Fengwu Lin. CtBP1 promotes tumour‐associated macrophage infiltration and progression in non–small‐cell lung cancer. Journal of Cellular and Molecular Medicine 2020; 24(19): 11445 doi: 10.1111/jcmm.15751
|
7 |
Zhen Zhao, Baoping Zheng, Jianglin Zheng, Yi Zhang, Cheng Jiang, Chuansheng Nie, Xiaobing Jiang, Dongxiao Yao, Hongyang Zhao. Integrative Analysis of Inflammatory Response-Related Gene for Predicting Prognosis and Immunotherapy in Glioma. Journal of Molecular Neuroscience 2023; 73(7-8): 608 doi: 10.1007/s12031-023-02142-x
|
8 |
Irina Larionova, Elena Kazakova, Tatiana Gerashchenko, Julia Kzhyshkowska. New Angiogenic Regulators Produced by TAMs: Perspective for Targeting Tumor Angiogenesis. Cancers 2021; 13(13): 3253 doi: 10.3390/cancers13133253
|
9 |
Semaphorin 3D promotes pancreatic ductal adenocarcinoma progression and metastasis through macrophage reprogramming. Science Advances 2024; 10(42) doi: 10.1126/sciadv.adp0684
|
10 |
Jun Liang, Jing Wu, Fei Wang, Pengfei Zhang, Xuemei Zhang. Semaphoring 4D is required for the induction of antioxidant stress and anti-inflammatory effects of dihydromyricetin in colon cancer. International Immunopharmacology 2019; 67: 220 doi: 10.1016/j.intimp.2018.12.025
|
11 |
Janine König, Matjaz Rokavec, Meryem Gülfem Öner-Ziegler, Ye Fei, Heiko Hermeking. Myeloid Mir34a suppresses colitis-associated colon cancer: characterization of mediators by single-cell RNA sequencing. Cell Death & Differentiation 2024; doi: 10.1038/s41418-024-01380-9
|
12 |
Cecilia Bica, Alexandru Tirpe, Andreea Nutu, Cristina Ciocan, Sergiu Chira, Eugen S. Gurzau, Cornelia Braicu, Ioana Berindan-Neagoe. Emerging roles and mechanisms of semaphorins activity in cancer. Life Sciences 2023; 318: 121499 doi: 10.1016/j.lfs.2023.121499
|
13 |
Yang Lyu, Fuda Xie, Bonan Chen, Wing Sum Shin, Wei Chen, Yulong He, Kam Tong Leung, Gary M. K. Tse, Jun Yu, Ka Fai To, Wei Kang. The nerve cells in gastrointestinal cancers: from molecular mechanisms to clinical intervention. Oncogene 2024; 43(2): 77 doi: 10.1038/s41388-023-02909-x
|
14 |
Damon Fard, Luca Tamagnone. Semaphorins in health and disease. Cytokine & Growth Factor Reviews 2021; 57: 55 doi: 10.1016/j.cytogfr.2020.05.006
|
15 |
Jun Jiang, Fang Zhang, Yi Wan, Ke Fang, Ze-dong Yan, Xin-ling Ren, Rui Zhang. Semaphorins as Potential Immune Therapeutic Targets for Cancer. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.793805
|
16 |
Satoshi Nojima. Class IV semaphorins in disease pathogenesis. Pathology International 2022; 72(10): 471 doi: 10.1111/pin.13270
|
17 |
Shujie Zeng, Zihao Zhang, Chunshui Ye, Jinshen Wang, Changqing Jing, Leping Li. Mediating immunosuppressive functions: a new perspective on the complex immunological properties of SEMA4D in the tumor microenvironment. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1171926
|